TOVX Theriva Biologics Inc

Price (delayed)

$0.28

Market cap

$12.85M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.13

Enterprise value

$2.07M

?
Relative Growth: Rel. Growth: 21
Relative Strength: Rel. Strength: 66
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 30

Synthetic Biologics, Inc. is a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need. The Company's ...

Highlights
Theriva Biologics's EPS has soared by 92% YoY and by 46% from the previous quarter
The quick ratio has increased by 14% YoY and by 8% from the previous quarter
The debt has increased by 40% since the previous quarter and by 29% year-on-year

Key stats

What are the main financial stats of TOVX

TOVX stock price

How has the Theriva Biologics stock price performed over time
Intraday
-2.78%
1 week
-9.39%
1 month
-26.26%
1 year
-38.86%
YTD
33.08%
QTD
43%

Financial performance

How have Theriva Biologics's revenue and profit performed over time
Revenue
$300,000
Gross profit
$300,000
Operating income
-$21.76M
Net income
-$21.46M
Gross margin
100%
Net margin
-7,153%
The company's operating income rose by 14% YoY and by 10% QoQ
The net income has increased by 14% YoY and by 10% QoQ

Price vs fundamentals

How does TOVX's price correlate with its fundamentals

Growth

What is Theriva Biologics's growth rate over time

Valuation

What is Theriva Biologics stock price valuation
P/E
N/A
P/B
0.83
P/S
38.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.89
Theriva Biologics's EPS has soared by 92% YoY and by 46% from the previous quarter
TOVX's P/B is 115% above its 5-year quarterly average of 0.4 and 72% above its last 4 quarters average of 0.5

Efficiency

How efficient is Theriva Biologics business performance
The ROE has shrunk by 64% YoY but it is up by 9% QoQ
The ROA has grown by 13% from the previous quarter and by 3% YoY
The return on invested capital is up by 10% since the previous quarter and by 3.5% year-on-year

Dividends

What is TOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TOVX.

Financial health

How did Theriva Biologics financials performed over time
The total assets is 67% more than the total liabilities
Theriva Biologics's total liabilities has increased by 37% YoY
The total assets has grown by 19% YoY
The debt is 76% smaller than the equity
The debt to equity has grown by 41% from the previous quarter and by 33% YoY
The debt has increased by 40% since the previous quarter and by 29% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.